Blood Cancer Journal
Blood Cancer Journal is a journal indexed in SJR in Hematology and Oncology with an H index of 85. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 3690 €. The scope of the journal is focused on hematologic malignancies, blood cancer, immunology. It has an SJR impact factor of 5,139 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 5,139.
Blood Cancer Journal focuses its scope in these topics and keywords: patients, cell, nk, risk, monoclonal, prognostic, adversely, affected, dominant, fcgcllwm, ...
Unclaimed profile — some fields may be incomplete.
Metrics
Campos Scimago / CoP — sin series inventadas
SJR Impact
5,139
H-index
85
Docs (year)
220
Docs 3y
549
Total refs
7019
Cites 3y
4328
Citable 3y
308
Cites/Doc 2y
6.17
Ref/Doc
31.9
Immediate OA
3690 €
Embargoed OA
NPD
Non OA / Submission
- €
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.